NCT05339243View on ClinicalTrials.gov

Evaluating the Safety and Efficacy of the Probiotic Bifidobacterium Longum ES1 and the Post Biotic Heat-treated Bifidobacterium Longum ES1 (HT-ES1) on IBS Symptom Severity in Patients With Diarrhoea Predominant Irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

January 13, 2023

Study Completion Date

January 13, 2023

Conditions
Irritable Bowel Syndrome With Diarrhea
Interventions
OTHER

ES 1

Two capsules orally once daily after breakfast for 84 days

OTHER

HT ES1

Two capsules orally once daily after breakfast for 84 days

OTHER

Placebo

Two capsules orally once daily after breakfast for 84 days

Trial Locations (8)

302001

Dr. Sudhir Maharshi clinic, Jaipur

380013

Apex Gastro Clinic and Hospital, Ahmedabad

380054

Gastroplus, Digestive disease centre, Ahmedabad

390021

Aman Hospital and research centre, Vadodara

400059

Dr. Sanjeev Khanna clinic, Mumbai

Stress test clinic, Mumbai

-400067

Shantaee Nursing Home, Mumbai

-302017

Jaipur National University Institute for Medical Science & Research Centre, Jaipur

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY